Clinical trial
A Translational Study to Understand the Mechanism of Apolipoprotein CIII Reduction Via Colchicine
NCT02083510 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Translational Study to Understand the Mechanism of Apolipoprotein CIII Reduction Via Colchicine
- Lead sponsor
- Scripps Translational Science Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- May 31, 2014
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.